Ligand Pharmaceuticals :
LGND
LGND
Stock Data
$193.20
$0.23 (0.12%)
Asset Type
Common Stock
Exchange
NASDAQ
Currency
USD
Country
USA
Sector
HEALTHCARE
Industry
BIOTECHNOLOGY
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and licensing a diverse portfolio of therapeutic products. It has a range of treatments for multiple myeloma, acute lymphoblastic leukemia, rare kidney diseases, osteoporosis, and pneumococcal diseases among others. Its products include Kyprolis, Evomela, Rylaze, and Veklury for COVID-19 treatment. The company collaborates with industry giants like Amgen, Merck, and Pfizer, providing innovative solutions such as Captisol technology for drug formulation. Founded in 1987, Ligand is headquartered in Jupiter, Florida, contributing to healthcare advancements globally.
All Ligand Pharmaceuticals Articles
19 Articles